78
Participants
Start Date
December 9, 2019
Primary Completion Date
December 28, 2021
Study Completion Date
December 28, 2021
VIB4920
liquid for IV infusion following dilution in normal saline
Placebo
0.9% saline for IV infusion
Research Site, Duncansville
Research Site, Wheaton
Research Site, Rocky Mount
Research Site, Salisbury
Research Site, Charlotte
Research Site, Atlanta
Research Site, Miami Lakes
Research Site, Margate
Research Site, Zephyrhills
Research Site, Clearwater
Research Site, Anniston
Research Site, Lexington
Research Site, Vandalia
Research Site, Norman
Research Site, Dallas
Research Site, Baytown
Research Site, Sun City
Research Site, Upland
Research Site, Poznan
Research Site, Krakow
Research Site, Nadarzyn
Research Site, Siedlce
Research Site, Bialystok
Research Site, Elblag
Research Site, Warsaw
Lead Sponsor
Amgen
INDUSTRY